
Attovia Therapeutics (NASDAQ: ATTO) — $289M IPO, Near Historical Lows at $17.80, $40 Analyst Target. Is This the Entry Point Before Q4 Data?
The global atopic dermatitis market reached $21.15 billion in 2026 and is projected to grow at 9.5% CAGR to $33.3…



















